- Home
- ICON vs INM Comparison
ICON vs INM Comparison
Compare ICON & INM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ICON
- INM
- Stock Information
- Founded
- ICON 2023
- INM 1981
- Country
- ICON Greece
- INM Canada
- Employees
- ICON N/A
- INM N/A
- Industry
- ICON
- INM Biotechnology: Pharmaceutical Preparations
- Sector
- ICON
- INM Health Care
- Exchange
- ICON Nasdaq
- INM Nasdaq
- Market Cap
- ICON 3.6M
- INM 3.2M
- IPO Year
- ICON 2024
- INM N/A
- Fundamental
- Price
- ICON $1.68
- INM $2.49
- Analyst Decision
- ICON Strong Buy
- INM
- Analyst Count
- ICON 1
- INM 0
- Target Price
- ICON $4.50
- INM N/A
- AVG Volume (30 Days)
- ICON 64.6K
- INM 218.1K
- Earning Date
- ICON 06-10-2025
- INM 05-12-2025
- Dividend Yield
- ICON 206.67%
- INM N/A
- EPS Growth
- ICON N/A
- INM N/A
- EPS
- ICON N/A
- INM N/A
- Revenue
- ICON $5,309,000.00
- INM $4,920,990.00
- Revenue This Year
- ICON $76.76
- INM N/A
- Revenue Next Year
- ICON $30.43
- INM N/A
- P/E Ratio
- ICON N/A
- INM N/A
- Revenue Growth
- ICON 18.61
- INM N/A
- 52 Week Low
- ICON $1.60
- INM $1.72
- 52 Week High
- ICON $154.00
- INM $15.70
- Technical
- Relative Strength Index (RSI)
- ICON N/A
- INM 43.88
- Support Level
- ICON N/A
- INM $2.34
- Resistance Level
- ICON N/A
- INM $2.90
- Average True Range (ATR)
- ICON 0.00
- INM 0.45
- MACD
- ICON 0.00
- INM -0.04
- Stochastic Oscillator
- ICON 0.00
- INM 21.35
About ICON Icon Energy Corp. Common stock
Icon Energy Corp is a Growth-oriented company that operates as a holding company for the purpose of acquiring, owning, chartering and operating dry bulk vessels through its subsidiaries. The company generates its revenues by chartering the Initial Vessels to regional and international dry bulk operators, commodity traders and end users.
About INM InMed Pharmaceuticals Inc.
InMed Pharmaceuticals Inc is a Canada based clinical-stage biopharmaceutical company. The company is engaged in the research and development of novel, cannabinoid-based, and manufacturing of Pharmaceutical grade cannabinoids. Its product portfolio includes INM-755, which is used for the treatment of epidermolysis bullosa; INM-088 for the treatment of glaucoma; INM-901 for Alzheimer's disease, INM-089's pharmacological and IntegraSyn which is a manufacturing system for Pharmaceutical-Grade Cannabinoids.